Retracted: Cell Division Cycle-Associated Protein 3 (CDCA3) Is a Potential Biomarker for Clinical Prognosis and Immunotherapy in Pan-Cancer

Biomed Res Int. 2023 Jun 21:2023:9870382. doi: 10.1155/2023/9870382. eCollection 2023.

Abstract

[This retracts the article DOI: 10.1155/2022/4632453.].

Publication types

  • Retraction of Publication